muvalaplin (LY3473329) - Eli Lilly
Leqvio (inclisiran) - Novartis
vupanorsen (AKCEA-ANGPTL3-LRx) - Ionis, Pfizer
gemcabene (CI-1027) - Dong-A
pelacarsen (AKCEA-APO(a)-LRx) - Novartis
Waylivra (volanesorsen) - Ionis
zerlasiran (SLN360) - Silence Therap
obicetrapib (TA-8995) - NewAmsterdam Pharma
Juxtapid (lomitapide) - Novelion, Chiesi
Nexletol (bempedoic acid) - Esperion Therap, CSL Behring
Evkeeza (evinacumab-dgnb) - Regeneron
Lerochol (lerodalcibep-liga) - LIB Therap
Tryngolza (olezarsen) - Ionis
olpasiran (AMG 890) - Amgen
lepodisiran (LY3819469) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/41616414
 
Ali H Eid; Amirhossein Sahebkar; Arrigo F G Cicero; Maryam Mahjoubin-Tehran; Tannaz Jamialahmadi; Ċ½eljko Reiner
 
Jan 31, 2026
 
Next